CYTOF Altamira Therapeutics Ltd.
Price Chart
Executive Summary
Altamira Therapeutics Ltd. (CYTOF) has filed Form 15-12G to terminate the registration of its common shares under Section 12(g) of the Securities Exchange Act of 1934 and suspend its reporting obligations with the SEC. The company cites a low number of shareholders of record (approximately 48), qualifying it for deregistration under Rule 12g-4(a)(1).
Actionable Insight
Traders should anticipate reduced liquidity and limited financial disclosures going forward. The lack of ongoing SEC reporting increases information asymmetry, which may widen bid-ask spreads and increase volatility. Monitor OTC trading volume and consider exiting positions if transparency becomes a concern.
Key Facts
- Altamira Therapeutics Ltd. is terminating the registration of its common shares under Section 12(g) of the Exchange Act.
- The company has approximately 48 holders of record, below the 300-shareholder threshold for mandatory registration under Section 12(g).
- No acquisition or going-private transaction is indicated; this is a voluntary deregistration due to low shareholder count.
- The filing was effective February 27, 2026, meaning the company will no longer file periodic reports (10-K, 10-Q) or current reports (8-K).
- Securities are expected to continue trading on the OTC market, but with reduced transparency and liquidity.
Financial Impact
Non-financial in terms of direct dollar impact, but significant in reducing disclosure and investor access to information.
Risk Factors
- Loss of regulatory disclosure requirements increases information risk for investors.
- Potential decline in trading volume and market maker interest due to 'going dark' status.
- Difficulty in valuation without audited financials or management discussion.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001213900-26-021580 |
| Document: 0001213900-26-021580-index-headers.html | 0001213900-26-021580 |
| Document: 0001213900-26-021580-index.html | 0001213900-26-021580 |
| Document: 0001213900-26-021580.txt | 0001213900-26-021580 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access